Please select a Capability in order to start your service request.
SAN DIEGO, CA, June 25, 2014 /PRNewswire/ – The CareFusion Foundation today awarded $500,000 in grant funding to 11 U.S. nonprofit health care institutions as part of the Foundation's second annual Clinical Excellence Grant Program. The institutions will receive grants of up to $50,000 based on programs that develop and share best practices in improving medication safety and efficiency.
"The proper management of medications – from the physician order to the pharmacy to the nursing station to the patient bedside – is a critical issue for health care institutions nationwide," said Dr. Carlos Nunez, chief medical officer for CareFusion. "Working with these nonprofit partners to develop and share best practices for medication management will advance the field at large and help providers deliver safer, more cost-effective care."
After focusing on infection prevention in its first year, the Clinical Excellence Grant Program this year sought proposals for improving medication safety and efficiency, including reducing medication errors, improving clinician workflow, increasing pharmacy efficiency and driving medication use compliance. Together, through both grant cycles, the CareFusion Foundation has awarded $1 million to advancing health care best practices.
This year's recipients will address inter-departmental and inter-facility communication practices, patient intervention and reminder systems, medication reconciliation processes, and educational programs to improve medication adherence, and include:
To be eligible for a one-time grant of up to $50,000 per organization, U.S.-based nonprofit health care institutions were invited to submit a written proposal detailing their program plan and expected results. Preference was given to evidence-based programs with potential to serve as best practice models.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.